FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo

  • 📰 Medscape
  • ⏱ Reading Time:
  • 51 sec. here
  • 21 min. at publisher
  • 📊 Quality Score:
  • News: 90%
  • Publisher: 55%

Rheumatoid Arthritis News

RA - Rheumatoid Arthritis,Rheumatoid Arthritis (RA),Biologic Therapy

Unlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.

This high-concentration formulation offers a 50% reduction in injection volume and is available as a prefilled syringe or prefilled autoinjector.

"With this FDA approval, we are now able to offer both high- and low-concentration, citrate-free formulations of Cyltezo, further expanding treatment access for patients living with certain chronic inflammatory diseases," said Stephen Pagnotta, executive director and biosimilar commercial lead at Boehringer Ingelheim, in a press release.

Adalimumab-adbm is used in adults to treat moderate to severe rheumatoid arthritis; moderate to severe chronic plaque psoriasis; moderate to severe; psoriatic arthritis; ankylosing spondylitis; and noninfectious intermediate, posterior, and panuveitis.

The high concentration version of adalimumab-adbm does not have an interchangeable designation from the FDA, a Boehringer Ingelheim spokesperson told; however, the agency"has acknowledged that Boehringer Ingelheim has fulfilled the requirements to receive the interchangeability designation," he said. It is not clear if or when the FDA will grant this designation.

RA - Rheumatoid Arthritis Rheumatoid Arthritis (RA) Biologic Therapy Biologics Uveitis Biosimilars Biosimilar Drugs Follow-On Biologics Grant Psoriatic Arthritis Arthropathic Psoriasis Psoriatic Arthropathy Psa Juvenile Rheumatoid Arthritis Juvenile Ra Juvenile Idiopathic Arthritis Ankylosing Spondylitis Rheumatoid Spondylitis Rheumatoid Arthritis Of The Spine

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

High schools to high majors: Final Four includes 3 coaches with roots in high schoolAlabama coach Nate Oats had become comfortable coaching at Romulus High School outside of Detroit. His desire to take any Division I college coaching job waned through the years before he got an opportunity on Bobby Hurley's staff at Buffalo.
Source: AP - 🏆 728. / 51 Read more »

High schools to high majors: Final Four includes 3 coaches with roots in high schoolMontgomery, Alabama
Source: ALNewsNetwork - 🏆 583. / 51 Read more »

FDA OKs Subcutaneous Vedolizumab for Crohn's Maintenance TherapySubcutaneous administration of vedolizumab is now approved for maintenance therapy in adults with moderate to severe active Crohn's disease after induction therapy with intravenous vedolizumab.
Source: Medscape - 🏆 386. / 55 Read more »

FDA OKs Benralizumab for Asthma in Children as Young as 6 YearsThe maintenance treatment for severe asthma with an eosinophilic phenotype originally was approved for patients aged 12 years and older.
Source: Medscape - 🏆 386. / 55 Read more »

FDA OKs First CAR T-cell Trial for Children With LupusThe trial is expected to begin this summer and will enroll 12 individuals under age 18 years.
Source: Medscape - 🏆 386. / 55 Read more »

Carroll High School, Carroll Senior High School closed Wednesday due to ‘potential threat'Carroll High School and Carroll Senior High School to be closed after the North Texas schools received a threat.
Source: NBCDFW - 🏆 288. / 63 Read more »